Bone Biologics BBLG
NASDAQ BBLG
$0.49 -0.01 (-1.29%)
As of: Sep 30, 2026 · 10:16 AM EDT

Bone Biologics (BBLG) Receivables - Accured (2025 - 2026)

Updated

Bone Biologics' Receivables - Accured came in at $6,986 for Q2 2026.

Analysis

Bone Biologics (BBLG) Receivables - Accured (2025 - 2026) Analysis & Trends

At the end of FY2025, Bone Biologics' Receivables - Accured was $9,895.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables - Accured (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn -
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn -
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn -
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn -
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn -
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn -
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn -
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn -
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn -
10 Bone Biologics 905,190.00 905,190.00 - 6,986.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6,986.00
Dec 31, 2025 9,895.00
API Access

Bone Biologics Receivables - Accured API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-accured&ticker=BBLG&period=max&api_key=YOUR_API_KEY